BRAINLIFE.ORG





Current Neuro-Oncology




Volume 26 Number 5
15 March 2024




Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 5, 15 March






*Cioffi G, Waite KA, Dmukauskas M, Glantz M, Aulakh S, Nicolaides T, Sengupta S, Xiu J, Barnholtz-Sloan JS.
Sex differences in glioblastoma response to treatment: Impact of MGMT methylation.
Neurooncol Adv. 2024 Mar 1;6(1):vdae031. doi: 10.1093/noajnl/vdae031. PMID: 38476929. Observational study. ˍ




de Blank PMK, Lange KR, Xing M, Mirzaei Salehabadi S, Srivastava D, Brinkman TM, Ness KK, Oeffinger KC, Neglia J, Krull KR, Nathan PC, Howell R, Turcotte LM, Leisenring W, Armstrong GT, Okcu MF, Bowers DC.
Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study.
Nat Cancer. 2024 Mar 1. doi: 10.1038/s43018-024-00733-0. PMID: 38429413. Observational study˰ ˍ




Gómez Vecchio T, Rydén I, Ozanne A, Blomstrand M, Carstam L, Smits A, Jakola AS.
Global health status and fatigue score in isocitrate dehydrogenase-mutant diffuse glioma grades 2 and 3: A longitudinal population-based study from surgery to 12-month follow-up.
Neurooncol Pract. 2024 Mar 1;11(3):347-357. doi: 10.1093/nop/npae017. PMID: 38737607. Observational study. ˍ




Tsang DS, Tsui G, Santiago AT, Keller H, Purdie T, Mcintosh C, Bauman G, La Macchia N, Parent A, Dama H, Ahmed S, Laperriere N, Millar BA, Liu V, Hodgson DC.
A Prospective Study of Machine Learning-Assisted Radiotherapy Planning for Patients Receiving 54 Gy to the Brain.
Int J Radiat Oncol Biol Phys. 2024 Mar 1:S0360-3016(24)00334-1. doi: 10.1016/j.ijrobp.2024.02.022. PMID: 38432285. Observational study. ˍ




Feychting M, Schüz J, Toledano MB, Vermeulen R, Auvinen A, Harbo Poulsen A, Deltour I, Smith RB, Heller J, Kromhout H, Huss A, Johansen C, Tettamanti G, Elliott P.
Mobile phone use and brain tumour risk - COSMOS, a prospective cohort study.
Environ Int. 2024 Mar 2;185:108552. doi: 10.1016/j.envint.2024.108552. PMID: 38458118. Observational study. ˍ




Mankuzhy NP, Tringale KR, Dunkel IJ, Farouk Sait S, Souweidane MM, Khakoo Y, Karajannis MA, Wolden S.
Hypofractionated re-irradiation for diffuse intrinsic pontine glioma.
Pediatr Blood Cancer. 2024 Mar 2:e30929. doi: 10.1002/pbc.30929. PMID: 38430472. Observational study. ˍ




Lai S, Li P, Liu X, Liu G, Xie T, Zhang X, Wang X, Huang J, Tang Y, Liu Z, Shen G, Li C, Lu F, Wang L, Jiang F, Sun C, Chen Y, Chen M.
Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial.
Cancer Biol Med. 2024 Mar 4:j.issn.2095-3941.2023.0373. doi: 10.20892/j.issn.2095-3941.2023.0373. PMID: 38445445. Interventional study. ˍ




Cacciotti C, Lenzen A, Self C, Pillay-Smiley N.
Recurrence Patterns and Surveillance Imaging in Pediatric Brain Tumor Survivors.
J Pediatr Hematol Oncol. 2024 Mar 5. doi: 10.1097/MPH.0000000000002850. PMID: 38447113. Observational study. ˍ




Arrillaga-Romany I, Lassman A, McGovern SL, Mueller S, Nabors B, van den Bent M, Vogelbaum M, Allen JE, Melemed AS, Tarapore RS, Wen PY, Cloughesy T.
ACTION: A randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma.
Neuro Oncol. 2024 Mar 6:noae031. doi: 10.1093/neuonc/noae031. PMID: 38445964. Interventional study. ˍ




*Pasqualetti F, Gabelloni M, Faggioni L, Aquaro GD, De Vietro F, Mendola V, Spina N, Frey J, Montemurro N, Cantarella M, Caccese M, Gadducci G, Giannini N, Valenti S, Morganti R, Ius T, Caffo M, Vergaro G, Cosottini M, Naccarato AG, Lombardi G, Bocci G, Neri E, Paiar F.
Glioblastoma and Internal Carotid Artery Calcium Score: A Possible Novel Prognostic Partnership?
J Clin Med. 2024 Mar 6;13(5):1512. doi: 10.3390/jcm13051512. PMID: 38592330. Observational study. ˍ




*Alberghina C, Torrisi F, D'Aprile S, Longhitano L, Giallongo S, Scandura G, Mannino G, Mele S, Sabini MG, Cammarata FP, Russo G, Abdelhameed AS, Zappalà A, Lo Furno D, Giuffrida R, Li Volti G, Tibullo D, Vicario N, Parenti R.
Microglia and glioblastoma heterocellular interplay sustains tumour growth and proliferation as an off-target effect of radiotherapy.
Cell Prolif. 2024 Mar 7:e13606. doi: 10.1111/cpr.13606. PMID: 38454614. Laboratory investigation. ˍ




Brown CE, Hibbard JC, Alizadeh D, Blanchard MS, Natri HM, Wang D, Ostberg JR, Aguilar B, Wagner JR, Paul JA, Starr R, Wong RA, Chen W, Shulkin N, Aftabizadeh M, Filippov A, Chaudhry A, Ressler JA, Kilpatrick J, Myers-McNamara P, Chen M, Wang LD, Rockne RC, Georges J, Portnow J, Barish ME, D'Apuzzo M, Banovich NE, Forman SJ, Badie B.
Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial.
Nat Med. 2024 Mar 7. doi: 10.1038/s41591-024-02875-1. PMID: 38454126. Interventional study. ˍ




Breen WG, Geno CS, Waddle MR, Qian J, Harmsen WS, Burns TC, Sener UT, Ruff MW, Neth BJ, Uhm JH, Routman DM, Yan E, Kruse JJ, Laack NN, Brown PD, Mahajan A.
Proton versus photon craniospinal irradiation for adult medulloblastoma: A dosimetric, toxicity, and exploratory cost analysis.
Neurooncol Adv. 2024 Mar 8;6(1):vdae034. doi: 10.1093/noajnl/vdae034. PMID: 38550393. Observational study. ˍ




Di Nunno V, Lombardi G, Simonelli M, Minniti G, Mastronuzzi A, Di Ruscio V, Corrà M, Padovan M, Maccari M, Caccese M, Simonetti G, Berlendis A, Farinotti M, Pollo B, Antonelli M, Di Muzio A, Dipasquale A, Asioli S, De Biase D, Tosoni A, Silvani A, Franceschi E.
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study.
J Neurooncol. 2024 Mar 8. doi: 10.1007/s11060-024-04589-3. PMID: 38457090. Observational study˰ ˍ




Komlodi-Pasztor E, Munjapara V, Eberhart CG, Bazer DA, Sherief MR, Kamson DO, Ye X, Ozer BH, Holdhoff M.
Postradiation platinum-etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity.
CNS Oncol. 2024 Mar 8:CNS107. doi: 10.2217/cns-2023-0029. PMID: 38456492. Observational study. ˍ




Lenga P, Kleineidam H, Unterberg A, Dao Trong P.
Optimizing patient outcome in intracranial tumor surgery: a detailed prospective study of adverse events and mortality reduction strategies in neurosurgery.
Acta Neurochir (Wien). 2024 Mar 8;166(1):126. doi: 10.1007/s00701-024-06008-y. PMID: 38457057. Observational study. ˍ




Hudson EM, Noutch S, Webster J, Brown SR, Boele FW, Al-Salihi O, Baines H, Bulbeck H, Currie S, Fernandez S, Hughes J, Lilley J, Smith A, Parbutt C, Slevin F, Short S, Sebag-Montefiore D, Murray L.
Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) - protocol for a multi-centre open-label randomised trial.
BMJ Open. 2024 Mar 8;14(3):e078926. doi: 10.1136/bmjopen-2023-078926. PMID: 38458809. Interventional study protocol. ˍ




Ying Z, Yang W, Zhang N, Sun H, Zhang D, Shang B, Chen J, Ge M.
Risk factors for postoperative ventriculoperitoneal shunt requirement in pediatric patients with brain tumors invading or adjacent to CSF circulation pathways.
J Neurosurg Pediatr. 2024 Mar 8:1-8. doi: 10.3171/2024.1.PEDS23225. PMID: 38457814. Observational study˰ ˍ




*Kozel G, Gurses ME, Gecici NN, Gökalp E, Bahadir S, Merenzon MA, Shah AH, Komotar RJ, Ivan ME.
Chat-GPT on brain tumors: An examination of Artificial Intelligence/Machine Learning's ability to provide diagnoses and treatment plans for example neuro-oncology cases.
Clin Neurol Neurosurg. 2024 Mar 9;239:108238. doi: 10.1016/j.clineuro.2024.108238. PMID: 38507989. Observational study˰ ˍ




Trip AK, Hedegaard Dahlrot R, Aaquist Haslund C, Muhic A, Rosendal Korshøj A, Laursen RJ, Rom Poulsen F, Skjøth-Rasmussen J, Lukacova S.
Patterns of care and survival in patients with multifocal glioblastoma: A Danish cohort study.
Neurooncol Pract. 2024 Mar 9;11(4):421-431. doi: 10.1093/nop/npae020. PMID: 39006522. Observational study˰ ˍ




Moreira DC, Qaddoumi I, Spiller S, Bouldin TW, Davidson A, Saba-Silva N, Sullivan DV, Tanaka R, Wagner AS, Wood M, Klimo P, Job G, Devidas M, Li X, Gajjar A, Robinson GW, Chiang J.
Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma.
Neuro Oncol. 2024 Mar 11:noae048. doi: 10.1093/neuonc/noae048. PMID: 38466086. Observational study. ˍ




Morin A, Allodji R, Kariyawasam D, Touraine P, Puget S, Beccaria K, De Carli E, Kieffer V, Rivollet S, Abbou S, Fayech C, Souchard V, Dufour C, De Vathaire F, Bolle S, Grill J, Fresneau B.
Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study.
Neuro Oncol. 2024 Mar 11:noae045. doi: 10.1093/neuonc/noae045. PMID: 38465768. Observational study˰ ˍ




Thomas-Joulié A, Tran S, El Houari L, Seyve A, Bielle F, Birzu C, Lozano-Sanchez F, Mokhtari K, Giry M, Marie Y, Laigle-Donadey F, Dehais C, Houillier C, Psimaras D, Alentorn A, Laurenge A, Touat M, Sanson M, Hoang-Xuan K, Kas A, Rozenblum L, Habert MO, Nichelli L, Leclercq D, Galanaud D, Jacob J, Karachi C, Capelle L, Carpentier A, Mathon B, Belin L, Idbaih A.
Prognosis of glioblastoma patients improves significantly over time interrogating historical controls.
Eur J Cancer. 2024 Mar 11;202:114004. doi: 10.1016/j.ejca.2024.114004. PMID: 38493668. Observational study. ˍ




*Coman DL, Chard MP, Desautels L, Lutz BJ, Minns LA.
What do spouse primary caregivers of patients with glioblastoma want medical providers to know? A qualitative thematic reflexive analysis of letters written by primary caregivers from a secret Facebook support group.
BMJ Open. 2024 Mar 12;14(3):e081783. doi: 10.1136/bmjopen-2023-081783. PMID: 38479741. Observational study. ˍ




Ek L, Elwin M, Neander K.
Neuropsychological longitudinal study of patients with low-grade gliomas: Cognitive impairment.
Appl Neuropsychol Adult. 2024 Mar 12:1-11. doi: 10.1080/23279095.2024.2325546. PMID: 38470840. Observational study˰ ˍ




Liu Y, Hu H, Han Y, Li Z, Yang J, Zhang X, Chen L, Chen F, Li W, Huang G.
Development and external validation of a novel score for predicting postoperative 30‑day mortality in tumor craniotomy patients: A cross-sectional diagnostic study.
Oncol Lett. 2024 Mar 12;27(5):205. doi: 10.3892/ol.2024.14338. PMID: 38516688. Observational study. ˍ




Bagley SJ, Logun M, Fraietta JA, Wang X, Desai AS, Bagley LJ, Nabavizadeh A, Jarocha D, Martins R, Maloney E, Lledo L, Stein C, Marshall A, Leskowitz R, Jadlowsky JK, Christensen S, Oner BS, Plesa G, Brennan A, Gonzalez V, Chen F, Sun Y, Gladney W, Barrett D, Nasrallah MP, Hwang WT, Ming GL, Song H, Siegel DL, June CH, Hexner EO, Binder ZA, O'Rourke DM.
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results.
Nat Med. 2024 Mar 13. doi: 10.1038/s41591-024-02893-z. PMID: 38480922. Interventional study˰ ˍ




Barry N, Koh ES, Ebert MA, Moore A, Francis RJ, Rowshanfarzad P, Hassan GM, Ng SP, Back M, Chua B, Pinkham MB, Pullar A, Phillips C, Sia J, Gorayski P, Le H, Gill S, Croker J, Bucknell N, Bettington C, Syed F, Jung K, Chang J, Bece A, Clark C, Wada M, Cook O, Whitehead A, Rossi A, Grose A, Scott AM.
[18]F-fluoroethyl-l-tyrosine positron emission tomography for radiotherapy target delineation: Results from a Radiation Oncology credentialing program.
Phys Imaging Radiat Oncol. 2024 Mar 13;30:100568. doi: 10.1016/j.phro.2024.100568. PMID: 38585372. Observational study. ˍ




Choi BD, Gerstner ER, Frigault MJ, Leick MB, Mount CW, Balaj L, Nikiforow S, Carter BS, Curry WT, Gallagher K, Maus MV.
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma.
N Engl J Med. 2024 Mar 13;390(14):1290-1298. doi: 10.1056/NEJMoa2314390. PMID: 38477966. Interventional study. ˍ




Cipri S, Del Baldo G, Carai A, Cacchione A, Agolini E, Novelli A, Rossi S, Colafati GS, Boccuto L, Mastronuzzi A.
A second case report of medulloblastoma in a patient carrying biallelic pathogenic MUTYH germline variants.
Neuropathol Appl Neurobiol. 2024 Mar 13;50(2):e12968. doi: 10.1111/nan.12968. PMID: 38477379. Case report. ˍ




Edelbach B, Gospodarev V, Lopez-Gonzalez M, Deisch J, Kaur M.
Unusual presentation of glioblastoma in the brainstem: a case report of a diffuse pontine glioblastoma multiforme and surgical management.
Front Oncol. 2024 Mar 13;14:1279897. doi: 10.3389/fonc.2024.1279897. PMID: 38544840. Case report. ˍ




Hansen ST, Jacobsen KS, Kofoed MS, Petersen JK, Boldt HB, Dahlrot RH, Schulz MK, Poulsen FR.
Prognostic factors to predict postoperative survival in patients with recurrent glioblastoma.
World Neurosurg X. 2024 Mar 13;23:100308. doi: 10.1016/j.wnsx.2024.100308. PMID: 38584878. Observational study. ˍ




Özkan A, Yağcı Küpeli B, Küpeli S, Sezgin G, Bayram İ.
Nimotuzumab-vinorelbine combination therapy versus other regimens in the treatment of pediatric diffuse intrinsic pontine glioma.
Childs Nerv Syst. 2024 Mar 13. doi: 10.1007/s00381-024-06329-4. PMID: 38478066. Observational study˰ ˍ




Crooms RC, Nnemnbeng JF, Taylor JW, Goldstein NE, Gorbenko K, Vickrey BG.
Clinician perspectives on integrating neuro-oncology and palliative care for patients with high-grade glioma.
Neurooncol Pract. 2024 Mar 14;11(4):404-412. doi: 10.1093/nop/npae022. PMID: 39006519. Observational study˰ ˍ
RELATED ARTICLE
Leeper HE. Palliative care in neuro-oncology: The elephant in the room.
Neurooncol Pract. 2024 Jun 14;11(4):367-368. doi: 10.1093/nop/npae053. PMID: 39006530. Comment˰ ˍ




Ebaid NY, Ahmed RN, Assy MM, Amin MI, Eldin AMA, Alsowey AM, Abdelhay RM.
Diagnostic Validity and Reliability of BT-RADS in the Management of Recurrent High-Grade Glioma.
J Neuroradiol. 2024 Mar 14:S0150-9861(24)00111-1. doi: 10.1016/j.neurad.2024.03.001. PMID: 38492800. Observational study˰ ˍ




Lulla RR, Buxton A, Krailo MD, Lazow MA, Boue DR, Leach JL, Lin T, Geller JI, Kumar SS, Nikiforova MN, Chandran U, Jogal SS, Nelson MD Jr, Onar-Thomas A, Haas-Kogan DA, Cohen KJ, Kieran MW, Gajjar A, Drissi R, Pollack IF, Fouladi M.
Vorinostat, temozolomide or bevacizumab with irradiation and maintenance BEV/TMZ in pediatric high-grade glioma: A Children's Oncology Group Study.
Neurooncol Adv. 2024 Mar 14;6(1):vdae035. doi: 10.1093/noajnl/vdae035. PMID: 38596718. Interventional study. ˍ




Soni N, Agarwal A, Ajmera P, Mehta P, Gupta V, Vibhute M, Gubbiotti M, Mark IT, Messina SA, Mohan S, Bathla G.
High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity.
AJNR Am J Neuroradiol. 2024 Mar 14. doi: 10.3174/ajnr.A8166. PMID: 38485198. Observational study˰ ˍ




Boele F, Rosenlund L, Nordentoft S, Melhuish S, Nicklin E, Rydén I, Williamson A, Donders-Kamphuis M, Preusser M, Le Rhun E, Kiesel B, Minniti G, Furtner J, Dirven L, Taphoorn M, Galldiks N, Rudà R, Chalmers A, Short SC, Piil K.
Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectives.
Neurooncol Pract. 2024 Mar 15;11(4):484-493. doi: 10.1093/nop/npae023. PMID: 39006521. Observational study˰ ˍ




Caccese M, Desideri I, Villani V, Simonelli M, Buglione M, Chiesa S, Franceschi E, Gaviani P, Stasi I, Caserta C, Brugnara S, Lolli I, Bennicelli E, Bini P, Cuccu AS, Scoccianti S, Padovan M, Gori S, Bonetti A, Giordano P, Pellerino A, Gregucci F, Riva N, Cinieri S, Internò V, Santoni M, Pernice G, Dealis C, Stievano L, Paiar F, Magni G, De Salvo GL, Zagonel V, Lombardi G.
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma.
ESMO Open. 2024 Mar 15;9(4):102943. doi: 10.1016/j.esmoop.2024.102943. PMID: 38492275. Observational study. ˍ




Casper D, Hayden J, Anthony M, Matthees N, Mushtaq R.
GammaTile: Reshaping Brachytherapy.
Radiol Imaging Cancer. 2024 Mar 15;6(2):e230208. doi: 10.1148/rycan.230208. PMID: 38488499. Case report. ˍ




Honeyman SI, Owen WJ, Mier J, Marks K, Dassanyake SN, Wood MJ, Fairhead R, Martinez-Soler P, Jasem H, Yarlagadda A, Roach JR, Boukas A, Stacey R, Apostolopoulos V, Plaha P.
Multiple surgical resections for progressive IDH wildtype glioblastoma-is it beneficial?
Acta Neurochir (Wien). 2024 Mar 15;166(1):138. doi: 10.1007/s00701-024-06025-x. PMID: 38488994. Observational study. ˍ




Mude P, Pradhan M, Tiwari A, Parida TK, Nayak MK, Sekar AK, Purkait S, Devi U.
Congenital brain tumour in a neonate: a therapeutic challenge.
BMJ Case Rep. 2024 Mar 15;17(3):e259646. doi: 10.1136/bcr-2024-259646. PMID: 38490704. Case report. ˍ




Wu Y, Han J, Li R, Chen J, Mao S, Zeng L.
Effect of memory therapy on enhancing postoperative cognitive function recovery and alleviating mood disturbances in brain glioma patients.
Am J Transl Res. 2024 Mar 15;16(3):998-1008. doi: 10.62347/UUTB6644. PMID: 38586107. Observational study. ˍ